Intelligence Hub
Market analytics and operational performance indicators
144 - September 16, 2025
Rocket Lab officer Frank Klein files Form 144 to sell 45,535 shares from RSU vesting.
Brief
This Form 144 discloses Rocket Lab officer Frank Klein's intent to sell 45,535 common shares (market value $2.23M) via Morgan Stanley, acquired via 81,250 RSUs vesting on 09/15/2025 as compensation. The sale covers tax obligations from the vesting. No prior sales in past 3 months; routine insider transaction.
Detailed Brief
Form 144 filed on 09/16/2025 by Frank Klein, an officer of Rocket Lab USA Inc. (NASDAQ: RKLB), notifies of proposed sale of 45,535 common shares at an aggregate market value of $2,229,648.60, with 483,960,665 shares outstanding. Shares originate from 81,250 restricted stock units vesting on 09/15/2025 as compensation from the issuer. The broker is Morgan Stanley Smith Barney LLC, with sale planned for 09/16/2025. Remarks note the sale includes shares to cover tax obligations from the vested equity award settlement. No securities sold by Klein in the past 3 months. Klein represents no undisclosed material adverse information. This is a standard Rule 144 filing for affiliates selling restricted securities post-vesting, common in tech/space firms like Rocket Lab to manage liquidity and taxes.
Key Telemetry
- • Frank Klein (Officer) to sell 45,535 common shares ($2.23M value) on 09/16/2025.
- • Shares from 81,250 RSUs vesting 09/15/2025 as compensation.
- • Sale covers tax obligations; no sales in prior 3 months.
- • ~0.009% of outstanding shares (483.96M total).
Impact Vector
Routine insider sale of vested RSUs to cover taxes; low dilution impact (negligible % of float). Signals no material adverse info per representation. Investors should monitor Klein's ongoing sales for patterns, but isolated tax-related transaction unlikely to affect stock price materially. Track RKLB's launch cadence and Q3 results for core drivers.